Eurofins Scientific SE
Eurofins Scientific SE (ERF.PA) Stock Competitors & Peer Comparison
See (ERF.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ERF.PA | €61.78 | -0.03% | 11B | 24.35 | €2.55 | +0.97% |
| BIM.PA | €89.75 | +0.11% | 10.5B | 26.77 | €3.34 | +1.01% |
| LBIRD.PA | €19.90 | -3.40% | 442.6M | 41.88 | €0.48 | N/A |
| MDXH.BR | €3.02 | -3.76% | 85.6M | -1.58 | -€1.91 | N/A |
| ALECR.PA | €16,100.00 | +0.00% | 81.2M | 13.17 | €1,222.20 | N/A |
| BCART.BR | €0.29 | +0.00% | 27.2M | -0.32 | -€0.92 | N/A |
| ALBIO.PA | €0.83 | -1.19% | 14.7M | -0.20 | -€3.98 | N/A |
| ALPRE.PA | €3.01 | -2.59% | 12.1M | -2.92 | -€1.06 | N/A |
| EEP.MC | €0.54 | N/A | 6.2M | -54.00 | -€0.01 | N/A |
| MLAHC.PA | €0.60 | +0.00% | 5.4M | -10.00 | -€0.06 | N/A |
Stock Comparison
ERF.PA vs BIM.PA Comparison April 2026
ERF.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERF.PA stands at 11B. In comparison, BIM.PA has a market cap of 10.5B. Regarding current trading prices, ERF.PA is priced at €61.78, while BIM.PA trades at €89.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERF.PA currently has a P/E ratio of 24.35, whereas BIM.PA's P/E ratio is 26.77. In terms of profitability, ERF.PA's ROE is +0.12%, compared to BIM.PA's ROE of +0.10%. Regarding short-term risk, ERF.PA is more volatile compared to BIM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ERF.PA.Check BIM.PA's competition here